Form 4 holding
SVP of Commercial Strategy and Market Development
Lyra Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 36,667
- Estimated value
- $108,674
- Report date
- 31 Jan 2023
- Price
- $2.96
- Ownership
- Direct